spacer
home > ict > winter 2017 > master the art
PUBLICATIONS
International Clinical Trials

Master the Art

Any initiative in relation to clinical trial master files (TMFs) should have a primary focus on delivering sustainable operational improvements to the business, such as improved:
  • Efficiency
  • Coordination internal (between functions) as well as external (sponsor, sites and CROs)
  • Transparency
  • Visibility into performance
  • Basis for decision-making allowing timely corrections
By focusing on delivering the above, a company will automatically achieve compliance and, at the same time, can decrease cost and enhance employee satisfaction.

Trial Master Files


A TMF is the collection of documentation that enables the conduct of the clinical trial, the integrity of study data and compliance with Good Clinical Practice (GCP) to be evaluated (EU Directive 2005/28/EC Article 16).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Badr Fathi is a Life Sciences R&D Consultant with a proven record of success in regulatory affairs, clinical development and compliance projects. As a subject matter expert within clinical and regulatory affairs, he is also responsible for the growth and development of the HighPoint Solutions European Life Sciences R&D practice from a delivery perspective.

Jens-Olaf Vanggaard is a strong team player and a results-driven Senior Life Sciences R&D Consultant at HighPoint Solutions. He has over 9 years of experience within clinical development and regulatory affairs implementing clinical data warehouses, metadata repositories, clinical trial management systems and eTMFs, helping more than five clients prepare for IDMP implementation.

spacer
Badr Fathi
spacer
spacer
spacer
Jens-Olaf Vanggaard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement